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Abstract
Background: Out-of-pocket (OOP) medical expenses often lead to catastrophic expenditure and impoverishment in
low- and middle-income countries. Yet, there has been no systematic examination of which specific diseases and
conditions (e.g., tuberculosis, cardiovascular disease) drive medical impoverishment, defined as OOP direct medical
costs pushing households into poverty.
Methods: We used a cost and epidemiological model to propose an assessment of the burden of medical
impoverishment in Ethiopia, i.e., the number of households crossing a poverty line due to excessive OOP direct
medical expenses. We utilized disease-specific mortality estimates from the Global Burden of Disease study,
epidemiological and cost inputs from surveys, and secondary data from the literature to produce a count of
poverty cases due to OOP direct medical costs per specific condition.
Results: In Ethiopia, in 2013, and among 20 leading causes of mortality, we estimated the burden of impoverishment
due to OOP direct medical costs to be of about 350,000 poverty cases. The top three causes of medical impoverishment
were diarrhea, lower respiratory infections, and road injury, accounting for 75 % of all poverty cases.
Conclusions: We present a preliminary attempt for the estimation of the burden of medical impoverishment by cause
for high mortality conditions. In Ethiopia, medical impoverishment was notably associated with illness occurrence and
health services utilization. Although currently used estimates are sensitive to health services utilization, a systematic
breakdown of impoverishment due to OOP direct medical costs by cause can provide important information for the
promotion of financial risk protection and equity, and subsequent design of health policies toward universal health
coverage, reduction of direct OOP payments, and poverty alleviation.
Keywords: Medical impoverishment, Catastrophic health expenditure, Out-of-pocket costs, Direct medical payments,
Financial risk protection, Poverty, Ethiopia
Background
High out-of-pocket (OOP) medical expenses can lead to
impoverishment in many low- and middle-income coun-
tries [1, 2]. Often, individuals and households resort to a
variety of strategies to cope with illness-related bills such
as borrowing money from peers or selling assets [3].
Without pre-existing financing arrangements, like social
insurance, household medical expenditure can often be
categorized as “catastrophic” – defined as exceeding
a certain fraction (e.g., 10 %) of total household
expenditure [2, 4].
Well-designed health policies are critical for the
minimization of financial risks tied to OOP direct
medical expenses. In this respect, the World Health
Organization’s 2010 World Health Report [5] argued for
pathways to universal health coverage (UHC) accounting
for the reduction of OOP direct payments and financial
risk protection as one essential dimension to measure
progress on the way to UHC. Likewise, the Sustainable
Development Goal for health (SDG3) included a sub-
target on achieving “universal health coverage, including
financial risk protection and access to quality essential
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health services” [6]. The prevention of medical impover-
ishment, defined here as OOP direct medical costs push-
ing households below the poverty line or leading to
catastrophic medical expenditure, is a major objective of
health systems and policy instruments such as insurance
and public finance [7]. Therefore, analyzing the compos-
ition of OOP direct medical payments per cause can
help design health systems better at preventing such
catastrophic expenditure, which have been estimated to
be substantial [8].
In the majority of low- and middle-income countries,
there is not necessarily a clear evidence base for the inter-
ventions to be covered by public finance [7, 9]. In particu-
lar, there has been no systematic examination of which
specific diseases and conditions (e.g., tuberculosis, heart
disease) drive OOP direct medical costs and subsequent
impoverishment. Such a systematic examination could
inform the design of an essential health benefits package.
Understanding the underlying composition of medical
impoverishment and its disaggregation per condition
can prove useful for several reasons. First, it can point to
the links between disease and poverty and be used to
examine the poverty consequences of epidemiological
changes and guide the implementation of tailored
poverty-focused policies. In this case, assessing illness-
related poverty would account for all the financial impli-
cations of disease, including OOP direct medical costs
(e.g., medications and consultation fees), transportation
costs, and indirect costs (e.g., time and income losses);
this is not the intent of this paper. Second, the disaggre-
gation of medical impoverishment, defined as OOP dir-
ect medical costs pushing households under the poverty
line, can help within the health sector in the design of
appropriate policy solutions which provide high financial
protection [10]. This approach can highlight the inter-
ventions to be financed by the health sector that can
prevent catastrophic medical expenditure. Thus, this
paper deliberately focuses on OOP direct medical pay-
ments only, as it is one essential dimension of UHC [5].
We propose a preliminary analytical approach to sys-
tematically assess the burden of impoverishment due to
OOP direct medical costs per condition in a given coun-
try. We intend to expose, with simplicity, a framework
which we subsequently apply to estimate medical impov-




We built on an existing cost and epidemiological model
[11] to assess medical impoverishment, defined as OOP
direct medical costs (e.g., consultation fees, payments for
medications) pushing households below a given poverty
line per condition in a given country.
The model incorporated a range of parameters, includ-
ing disease-specific mortality estimates (e.g., per cause of
death), case fatality ratios, patient OOP direct medical
costs, health services utilizations (e.g., healthcare seeking
behavior, such as the probability that a person seeks care
for a specific illness conditional on having that illness),
and wealth inputs (e.g., household income). The model
estimated the OOP direct medical costs related to a spe-
cific condition at the population level. Subsequently, it
calculated the corresponding number of cases of poverty
that could be attributed to OOP direct medical costs
tied to that specific condition. The quantification of
those medical poverty cases relied on counting the num-
ber of households crossing a defined poverty line (e.g.,
country poverty line) due to condition-related OOP
direct medical costs.
We applied the model to the case study of Ethiopia.
First, for simplicity, we selected 20 conditions estab-
lished as major causes of mortality in Ethiopia (whose
estimates were immediately available from the Global
Burden of Disease study [12]), and hence deemed to
likely incur substantial OOP direct medical costs. For
each condition, we obtained estimated mortality, from
which we derived the number of cases using a case fatal-
ity ratio (the number of cases would equal the number
of disease-related deaths divided by disease-specific case
fatality ratio); second, we estimated the associated OOP
direct medical costs. These costs included the direct
medical costs only – there was no accounting of trans-
port costs or time losses for the affected individuals, as
our study focused on catastrophic medical costs only. In
addition, we accounted for health services utilization,
the percentage of individuals seeking care for a specific
illness conditional on having that illness, and the com-
bination of OOP direct medical costs and utilization
allowed the estimation of incurred OOP direct medical
costs. Finally, using the inputs described above, supple-
mented by a distribution of income in the Ethiopian
population, we derived the total number of poverty cases
due to OOP direct medical payments that could be
attributed to each of the 20 conditions in Ethiopia.
Input data
First, we used causes of death data as provided by the
Global Burden of Disease study [12] systematic estimates
for Ethiopia for the year 2013. This data was used for
three reasons: (1) the critical importance of leading
causes of mortality in global health priorities; (2) its sim-
plicity and tractability by restriction to 20 well-known
causes constituting a large share of total mortality (70 %
of the total deaths estimated in Ethiopia for 2013); and
(3) its immediate availability. As a comparator, no data
on disease-specific cases, incidence, or morbidity was
immediately available in a systematic way per condition
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as was available for the causes of death data used herein.
The causes of death included (1) communicable, mater-
nal, and perinatal causes (neonatal conditions, respira-
tory infections, HIV/AIDS, diarrhea, tuberculosis (TB),
malaria, meningitis, childhood vaccine-preventable
diseases); (2) non-communicable diseases (vascular or
diabetic, chronic respiratory, cirrhotic, cancers); and (3)
injuries (road traffic accidents). The 20 causes of death
captured approximately 70 % of the total deaths
estimated to have occurred in Ethiopia in 2013 [12].
Subsequently, for each cause of death, the number of
corresponding disease cases was calculated using a case
fatality ratio, i.e., dividing the number of disease-related
deaths by the disease-specific case fatality ratio (Table 1).
Second, we used health services utilization data from
various sources, including Ethiopia’s Demographic and
Health Survey [13] and additional available information
from the literature. This enabled us to quantify, among
the number of individuals who were ill, the fraction who
used the health services specifically addressing their
illness, and hence might have encountered OOP direct
medical payments for that illness. For example, for
diarrhea, this fraction corresponded to the percentage of
patients with diarrhea seeking either outpatient or
inpatient care; for TB, this fraction was derived from the
case detection rate of TB (Table 1; Additional file 1:
Section 1.1). For the conditions for which we did not
have utilization data (e.g., ischemic heart disease, stroke,
Table 1 Case fatality ratio, health services utilization (e.g., probability of seeking care conditional on being sick), and out-of-pocket
direct medical costs for 20 leading causes of mortality in Ethiopia





Lower respiratory infections (LRI) 1.1 % 27 %a; 9 %b $6a*; $51b* [13, 25, 26]
Diarrhea 0.1 31a; 1b 5a*; 59b* [13, 27–29]
Malaria 0.3 24a; 1b 2a; 4b [13, 30–33]
Tuberculosis 17.0 62 49 [34, 35]
Stroke 39.7 25a,c; 9b,c 146a**; 343b** [36–39]
Preterm birth complications 4.6 8d 43 Based on cesarean section provider unit cost
[40] and [13, 41–44]
HIV 6.2 68 5 [45–48]
Road injury 2.3 50c 75 Based on surgical procedure provider unit
cost [49] and [50]
Meningitis 27.0 27 66 Based on LRI inputs and [30, 51]
Ischemic heart disease 29.1 25a,c; 9b,c 338a**; 629b** [52, 53]
Cirrhosis 33.6 2 417 Based on [55] and estimated cancer
utilization, average out-of-pocket inpatient
cost for breast and cervical cancer, diabetes,
and cardiovascular disease
Measles 3.5 31a; 1b 5a; 59b Based on diarrhea inputs and [54]
Whooping cough 2.8 27a; 9b 6a; 51b Based on LRI inputs and [56]
Diabetes mellitus 21.0 25c 176 [57, 66]
Neonatal encephalopathy 3.9 3e 76 Based on intrapartum-related conditions




1.1 27a; 9b 7a; 56b Based on LRI inputs and [58]
Epilepsy 0.4 5 18 [59, 60]
Cervical cancer 66.7 2a; 1b 280a; 508b [61–63]
Asthma 0.2 27a; 9b 7a; 56b Based on LRI inputs and [65]
Breast cancer 54.7 2 431 [61, 63, 64]
aOutpatient care
bInpatient care
cAssumptions based on expert opinion (author STM and colleagues from Ethiopia’s Federal Ministry of Health)
dUtilization is estimated at 8.2 %: skilled birth attendance rate of 16.4 % [41] multiplied by 0.5 according to World Health Organization expert panel estimation for
effective coverage [42]
eUtilization is estimated at 3.3 %: skilled birth attendance rate of 16.4 % [41] multiplied by 0.2 according to World Health Organization expert panel estimation for
effective coverage [42]
*Memirie ST, Metafaria ZS, Norheim OF, Levin C, Verguet S, Johansson KA. Catastrophic health expenditure and impoverishment associated with pneumonia and
diarrhea treatment costs in Ethiopia. Under review
**Tolla MT, Norheim OF, Belayneh A, Amenu K, Abdisa SG, Verguet S, Johansson KA. Out-of-pocket expenditure for prevention and treatment of cardiovascular dis-
ease in general and specialized hospitals in Addis Ababa, Ethiopia. Under review
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road injury), we made assumptions based on expert
opinion (author STM). Services utilization included the
formal health sector as expenditure data were not avail-
able for the informal sector, and this study focused on
the direct payments to the formal health system.
Third, we used OOP direct medical costs data assem-
bled through a review of the literature for each condition.
Those costs included all direct medical OOP payments,
including registration, diagnostic, medications, and hos-
pital bed payments. For those conditions for which we did
not have OOP direct medical costs data, we used health
services provider costs data augmented by country public
and private health expenditure data (national health ac-
counts) [14], in order to derive modeled OOP direct med-
ical costs borne by households for those conditions.
Ethiopia’s latest national health accounts indicated that
the fraction of healthcare expenditure borne OOP by
households in 2011 was 2 % for HIV/AIDS, 14 % for mal-
aria, 28 % for reproductive health conditions, 36 % for TB,
48 % for child health conditions, and 53 % for “other” con-
ditions [14]. We used these percentage points to derive
OOP direct medical costs from health services provider
costs, when needed. For example, if the provider costs
were $100 for injuries (falling into the “other” category
above), then $53 would be assigned as OOP direct medical
costs for injuries. All costs figures were inflated to 2013
US$ using the US consumer price index time series from
the World Bank [15].
Fourth, in assigning household income, we assumed a
distribution of income in the country, as there was no
such distribution readily available for Ethiopia. We de-
rived a distribution of income drawn from a simulated
gamma distribution whose shape and scale parameters
were based on gross domestic product per capita (2013
US$ 505, the mean of the income distribution) and Gini
coefficient (0.33) [15–17]. For each occurrence of OOP
direct medical costs associated with a particular condi-
tion, we assigned an annual income extracted from the
income distribution. We also used the national poverty
line (about 30 % of the population was estimated to be
under Ethiopia’s poverty line in 2010, corresponding to
an income level of about $306) [15, 18]. Subsequently,
we estimated the number of households for whom the
size of OOP direct medical costs would push them
below the poverty line. A poverty case was counted
when first household income was above the poverty line
and second household income minus OOP direct med-
ical costs was below the poverty line (Additional file 1:
Section 1.2).
Sensitivity analysis
We conducted both probabilistic and univariate sen-
sitivity analyses. A probabilistic sensitivity analysis was
conducted using Monte Carlo simulations (n = 1000 trials)
where all key parameters (causes of death estimates, case
fatality ratios, utilizations, OOP direct medical costs) were
varied simultaneously. Uncertainty was included through
sampling n values for each parameter to which either a
gamma, beta, or normal distribution was assigned built on
each input’s mean and standard deviation resulting in n
samples. Extracting the 2.5 and 97.5 percentiles allowed
the determination of 95 % uncertainty ranges (URs),
which were reported with the results. Further details are
given in Additional file 1: Section 2.1.
Three univariate sensitivity analyses were performed.
First, we set (unrealistically) health services utilization
equally to 75 % (close to the highest observed utilization
among all conditions, i.e., HIV) across all 20 conditions, all
other things being equal (Additional file 1: Section 2.2.1).
Second, disease-specific cases, health services utilization,
and the size of OOP direct medical costs were varied
across the income distribution: (1) disease-specific cases
were assumed to be 1.5 times higher within the poorest
income quintile than in the richest income quintile; (2)
utilization was set to be 2.8 times higher among the richest
quintile than in the poorest quintile; (3) OOP direct
medical costs were assumed to be 2.9 times higher among
the richest than among the poorest (Additional file 1:
Section 2.2.2). Third, we used an alternative metric to cal-
culate medical impoverishment, i.e., we estimated the
number of cases of catastrophic health costs, counting the
number of households whose OOP direct medical costs
would exceed 20 % of annual income (Additional file 1:
Section 2.2.3). The first sensitivity analysis was meant to
address the fact that those individuals who forgo healthcare
because of a lack of available services are not always
counted in the analysis. The second one intended to
capture heterogeneity, including variations with socioeco-
nomic status. The third sensitivity analysis was meant to
illustrate the influence of the type of metric chosen for
estimating medical impoverishment.
All inputs used are gathered in Table 1 and all details
are collected in Additional file 1. All analyses were run
using the R statistical software (www.r-project.org).
Results
The 20 causes of mortality were ranked according to the
level of medical impoverishment due to OOP direct
costs they incurred, allowing us to infer what inputs
might have the largest impact based on cause of death,
OOP costs, and utilization (Table 2; Fig. 1).
The three top drivers of impoverishment, defined as
OOP direct medical costs pushing households below the
poverty line, were diarrhea, with approximately 164,000
poverty cases (95 % UR: 95,000–233,900; approximately
47 % (95 % UR: 32–58 %) of all 350,000 cases estimated);
lower respiratory infections, with approximately 59,000
cases (35,800–98,400; 17 % (10–27 %) of all cases); and
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Table 2 Estimated total number of poverty cases, defined as condition-specific out-of-pocket (OOP) direct medical costs pushing
households below the poverty line, for the base case scenario and for two sensitivity analyses ((1) 75 % utilization across all conditions
and (2) key inputs including disease-specific cases, utilization, and OOP direct medical costs varying across income), and deaths incurred
by each of 20 leading causes of mortality in Ethiopia. The share of poverty cases among all estimated cases and the ranking are also
indicated. In brackets are presented the 95 % uncertainty ranges (URs) for the base case
Cause of mortality Number of poverty cases due
to direct OOP medical costs
Number of poverty cases due
to direct OOP medical costs,
75 % utilization (1)
Number of poverty cases due
to direct OOP medical costs,




Diarrhea Count: 164,100 (95 % UR: 95,000–233,900)
Share: 46.7 % (95 % UR: 32.4–58.1 %)








Lower respiratory infections 59,200 (35,800–98,400)









Road injury 44,700 (24,200–74,800)



















Ischemic heart disease 13,100 (8400–20,300)



















































Whooping cough 4800 (2800–7700)
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road injuries, with approximately 45,000 cases (24,200–
74,800; 13 % (7–20 %) of all cases). The three bottom
conditions were breast cancer, with approximately 50
poverty cases (30–100, < 0.1 % of all cases); cervical
cancer, with approximately 70 cases (40–120, < 0.1 % of
all cases); and cirrhosis with approximately 390 cases
(200–600, 0.1 % of all cases) (Table 2). All three bottom
conditions had very low utilization rates (2 %).
We observed substantial impoverishment due to OOP
direct medical costs for diarrhea and lower respiratory infec-
tions (Fig. 1a). The distribution of medical impoverishment
by cause became much tighter (road injuries, TB, and
ischemic heart disease, then representing 35 %, 11 %, and
10 % of all remaining poverty cases, respectively), when
both diarrhea and lower respiratory infections were
removed from the analysis. Moreover, we observed that a
large number of non-communicable diseases (e.g.,
ischemic heart disease, asthma, stroke) led to substantial
medical impoverishment (Fig. 1b). Some of the important
drivers of the medical impoverishment findings seemed to
be health services utilization and the number of illness
cases, much less so though when, again, diarrhea and
Table 2 Estimated total number of poverty cases, defined as condition-specific out-of-pocket (OOP) direct medical costs pushing
households below the poverty line, for the base case scenario and for two sensitivity analyses ((1) 75 % utilization across all conditions
and (2) key inputs including disease-specific cases, utilization, and OOP direct medical costs varying across income), and deaths incurred
by each of 20 leading causes of mortality in Ethiopia. The share of poverty cases among all estimated cases and the ranking are also
indicated. In brackets are presented the 95 % uncertainty ranges (URs) for the base case (Continued)
Cirrhosis 400 (200–600)









Cervical cancer <100 (0–100)









Breast cancer < 100 (0–100)









Fig. 1 a Numbers of poverty cases due to out-of-pocket (OOP) direct medical costs and deaths incurred by each of 20 leading causes of mortality
in Ethiopia. Lri = lower respiratory infections, Dia = diarrhea, St = stroke, TB = tuberculosis, Ihd = ischemic heart disease, Pr = preterm birth complications,
Mal = malaria, Rti = road traffic injuries, Neo = neonatal encephalopathy, Men = meningitis, Wc = whooping cough, Msl = measles, Cir = cirrhosis, DM
= diabetes mellitus, Copd = chronic obstructive pulmonary disease, Cc = cervical cancer, Bc = breast cancer, Ep = epilepsy, Ast = asthma. b Numbers
of poverty cases due to OOP direct medical costs and deaths incurred by each of 20 leading causes of mortality in Ethiopia, when the two leading
causes of mortality, lower respiratory infections and diarrhea, were omitted. Non-communicable diseases and injuries are indicated in blue;
communicable diseases, maternal, and neonatal causes are indicated in red
Verguet et al. BMC Medicine  (2016) 14:164 Page 6 of 11
lower respiratory infections were removed. On the other
hand, OOP direct medical costs seemed less of a driver.
When we unrealistically set health services utilization
to 75 % across all conditions, in other words, when ac-
cess barriers were fully removed, expectedly, the magni-
tude of impoverishment tied to OOP direct medical
costs was substantially augmented (Table 2; Fig. 2). This
confirmed that low utilization would impact on the
medical impoverishment findings. We observed a reor-
dering of rankings beyond the first three leading causes
of medical impoverishment (Table 2; Fig. 2a), and could
point to the contribution of reduced access to care in
the estimated small numbers of poverty cases for several
conditions in the base case (Fig. 2b).
When we varied key inputs (e.g., disease cases,
utilization, OOP direct medical costs) across the income
distribution, we found an overall reduction in the esti-
mated burden of medical impoverishment and almost all
conditions had such a decrease (Fig. 3a); yet, there were
only slight changes in rankings (Table 2). Further, we
examined the distribution of poverty cases incurred per
condition per income quintile (Fig. 3b). We found that
no poverty cases would occur among the bottom quin-
tile due to the use of the poverty case metric (i.e., those
already under the poverty line were not counted). We
observed a distinct distribution of medical impoverish-
ment across income quintiles depending on the condi-
tion: the conditions with large OOP direct medical costs
(e.g., stroke, ischemic heart disease) had all four quintiles
impacted, contrary to the conditions with small OOP
direct medical costs (e.g., asthma, COPD).
Finally, when we used an alternative metric of cases of
catastrophic health costs (Additional file 1: Section 2.2.3),
there was a change in the medical impoverishment rank-
ings. Notably, all income quintiles would now be impacted
by medical impoverishment (including those previously
under the poverty line).
Discussion
The purpose of this paper was to present a preliminary
attempt to systematically estimate medical impoverish-
ment by cause, and the difficulties inherent in making
such assessments.
In our case study of Ethiopia, we found that medical
impoverishment was tied to illness cases and health ser-
vices utilization. Cancers presented high OOP costs, but
the corresponding population-level medical impoverish-
ment was, in fact, small because countrywide cases of
cancer are low, and utilization difficult (Ethiopia has
only one cancer treatment center for the whole country,
located in a specialized hospital in the capital city of
Addis Ababa). However, when we omitted the two lead-
ing causes of mortality (lower respiratory infections and
diarrhea), we observed little overlap between disease-
specific mortality and impoverishment due to OOP
direct medical costs.
Fig. 2 a Number of poverty cases due to direct out-of-pocket (OOP) medical costs and number of deaths incurred by each of 20 leading causes
of mortality in Ethiopia, when health services utilization was hypothetically set at 75 % across all conditions. Non-communicable diseases and injuries are
indicated in blue; communicable diseases, maternal, and neonatal causes are indicated in red. b Number of poverty cases due to direct OOP medical costs
by each of 20 leading causes of mortality in Ethiopia, in the base case (orange) and when adding health services utilization set at 75 % across all conditions
(yellow). Lri = lower respiratory infections, Dia = diarrhea, St = stroke, TB = tuberculosis, Ihd = ischemic heart disease, Pr = preterm birth complications, Mal
= malaria, Rti = road traffic injuries, Neo = neonatal encephalopathy, Men = meningitis, Wc = whooping cough, Msl = measles, Cir = cirrhosis, DM =
diabetes mellitus, Copd = chronic obstructive pulmonary disease, Cc = cervical cancer, Bc = breast cancer, Ep = epilepsy, Ast = asthma
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This approach to medical impoverishment estimation
could, with more local data, enable policymakers to take
health-related payment criteria into account when de-
signing the architecture of health systems. Financial pro-
tection is central to achieving equity and fairness, and a
key component of UHC. While economic evaluations
have tended to focus on estimating health improvements
per dollar spent [19], newer methods, such as extended
cost-effectiveness analysis (ECEA) [11, 20], allow the
quantification of financial protection that can be pur-
chased by health policies. A systematic assessment like
ours aims at identifying both the proportion of individ-
uals impoverished by OOP direct medical costs and the
causes of such impoverishment. This can provide an evi-
dence base for efficient policy and planning. For in-
stance, in 2011 in Ethiopia, the main reason households
faced medical impoverishment was expenditure on drugs
[21], which suggested the need for appropriate prepay-
ment mechanisms for accessing healthcare. The govern-
ment began adopting community-based health insurance
and developing social health insurance [22]. A system-
atic approach quantifying the factors leading to medical
impoverishment can point to the causes which social
programs should address in order to improve financial
protection and equity for all.
Nonetheless, our preliminary attempt has several im-
portant limitations. First, we only describe the unidirec-
tional impact of illness on OOP medical impoverishment,
and do not include the impact of poverty on health.
Second, we deliberately focused on OOP direct medical
costs. Yet, there are a number of other factors in impover-
ishment. Transport costs and indirect costs, including loss
of earnings, may contribute significantly to poverty.
Illness-related poverty may be correlated with chronic
conditions (e.g., epilepsy) among productive adults,
leading to more wages lost than acute conditions (e.g.,
diarrhea). The illness and death of wage earners may
impoverish a family over a long time; as this suggests,
which individual is impacted in the family (child vs. bread-
winner) would matter. However, we were prevented from
including these considerations due to the lack of reliable
data across conditions. Third, our analysis critically points
to the importance of health services utilization data and
the inadequacy of current data at the national and global
levels. Further utilization data for a large number of con-
ditions is urgently needed. Before new data becomes avail-
able, an interim solution would be to estimate utilization
for selected groups of conditions (e.g., childhood condi-
tions, major infectious diseases, cancers), depending on
incidence, service availability, and recorded patient loads
for services in countries. The scarcity of data, including
the limited data on utilization but also on OOP costs or
private providers (e.g., traditional healers), influenced the
choice of our parsimonious modeling approach, relying on
secondary inputs and focusing on a limited number of
conditions. We restricted our study to leading causes of
Fig. 3 a Number of poverty cases due to direct out-of-pocket (OOP) medical costs by each of 20 leading causes of mortality in Ethiopia, in the base
case (orange) and when key inputs (e.g., disease-specific cases, utilization, OOP direct medical costs) were varied across the income distribution (yellow).
b Number of poverty cases due to direct OOP medical costs by each of 20 leading causes of mortality in Ethiopia, when key inputs (e.g., disease-specific
cases, utilization, OOP direct medical costs) were varied across the income distribution, including the repartition among income quintiles. Lri = lower
respiratory infections, Dia = diarrhea, St = stroke, TB = tuberculosis, Ihd = ischemic heart disease, Pr = preterm birth complications, Mal = malaria, Rti = road
traffic injuries, Neo = neonatal encephalopathy, Men = meningitis, Wc = whooping cough, Msl = measles, Cir = cirrhosis, DM = diabetes mellitus, Copd =
chronic obstructive pulmonary disease, Cc = cervical cancer, Bc = breast cancer, Ep = epilepsy, Ast = asthma
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mortality (and could not include causes of morbidity) as a
systematic assessment by cause was solely available for
mortality [12]. Yet, by examining high mortality condi-
tions only, our results may be biased against chronic con-
ditions for which payments may be repeated across long
time periods. Similarly, for some conditions, we relied on
macro-level indicators (e.g., sources of funding for health)
and on provider costs to derive OOP costs even though
OOP costs are not necessarily based on providers’ costs.
We did not include heterogeneity (e.g., geographical vari-
ation) in the model due to lack of data. For all these rea-
sons, we preferred a simple framework. We acknowledge
that many inputs (e.g., mortality, utilization, OOP costs)
present substantial uncertainty; our findings should be
interpreted with caution and future work should carefully
contextualize our analysis. Fourth, we chose to represent
disease-specific impoverishment due to OOP direct med-
ical costs in estimating a headcount of poverty cases in
spite of the shortcomings of such threshold-based metrics
[2]. Alternative metrics include the estimation of cases of
catastrophic health costs [4], insurance risk premiums
[20], or measures of downside risk arising from uninsured
expenditure [23]. We chose the cases of poverty metric
for its simplicity, and pursued a sensitivity analysis esti-
mating cases of catastrophic health costs. Further, OOP
payments were simply compared to income, not account-
ing for household borrowing capacity, which could lead to
underestimation of coping mechanisms and overesti-
mation of impoverishment [24].
Finally, our approach may mask the importance of the
size of OOP costs and the lack of access to care. Some
conditions may lead to large numbers of poverty cases
because care is available and hence incurs OOP costs
(e.g., road injuries), whereas others may lead to few
poverty cases as care is rarely available and thus little in
OOP costs can be expected (e.g., cancers). A focus on
current medical impoverishment and utilization patterns
is not able to distinguish between these two situations.
One of our sensitivity analyses is set at 75 % utilization
for all conditions in order to acknowledge this limita-
tion. Studying medical impoverishment must be un-
dertaken jointly with the contextual examination of
available health services. As greater medical impoverish-
ment may be driven by greater service availability, it
would be inadvisable to prioritize services on the basis
of greater medical impoverishment only. We emphasize
herein the potential financial catastrophes of private
financing for health services.
Conclusion
Our intentionally simple approach presents a prelimin-
ary attempt to systematically consider the catastrophic
consequences of OOP direct medical payments in low-
and middle-income countries and the difficulties in such
an undertaking. We hope it can be a departure point for
substantial empirical and analytical improvements. Our
framework represents a stepping stone toward highlight-
ing the importance of the financial protection benefits that
could be procured by the scale-up of health interventions.
Medical impoverishment findings complemented by the
effectiveness of benefits packages and social safety nets
can help estimate how much medical impoverishment
could be averted by the scale-up of health policies.
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